Home
Vigil Neuroscience

Vigil Neuroscience Market Share Analysis for June 2026

Sanofi is a research & development-driven, AI-powered healthcare biopharma company committed to improving lives through innovative medicines & vaccines.

Health > Biotechnology and Pharmaceuticals

Domainvigilneuro.com

Year Founded2020

Employees51 - 200

Annual Revenue--

Vigil Neuroscience

Vigil Neuroscience (including company regionals)

vigilneuro.com

See more website traffic and engagement information

Total visits to Vigil Neuroscience's top domains

Understand Vigil Neuroscience market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

vigilneuro.com--

See more with Sales Intelligence

Avg. visit duration in Vigil Neuroscience's top domains

Analyze Vigil Neuroscience engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Vigil Neuroscience's top domains

See how Vigil Neuroscience keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

vigilneuro.com--

See more with Sales Intelligence

Vigil Neuroscience top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Vigil Neuroscience

These are the website technologies, by industry, used by Vigil Neuroscience top domains

Content Management System (2)

Squarespace

Email Services (2)

Microsoft Exchange Online

Audio Video Media (1)

Vimeo

Business Solutions (1)

DocuSign

More Technologies

7

See all

News & Signals from Vigil Neuroscience

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsKaufmann leaves Vigilneuro as Chief Medical Officer.Dr. Kaufmann joins Ovid from Vigil Neuroscience (acquired by Sanofi), where she served as Chief Medical Officer and oversaw the company's medical, clinical, biomarker, patient advocacy and regulatory functions.

NewsSanofi is planning to acquire Vigilneuro.Sanofi has entered into an agreement to acquire Vigil.

NewsVigilneuro attended event Stifel 2025 Virtual CNS Forum on Mar 19th '25.WATERTOWN, Mass., March 11, 2025 (GLOBE NEWSWIRE) - Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that management will participate in a fireside chat at the Stifel 2025 Virtual CNS Forum on Wednesday, March 19, 2025, at 9:00 a.m. ET.